Specialty pharmaceutical company KemPharm, Inc. amended its collaboration and licensing agreement with an affiliate of Gurnet Point Capital (GPC).
Shares of KemPharm Inc. exploded 93% in Wednesday’s pre-market trading session after the US Food and Drug Administration (FDA) approved its treatment for …
Which names are capable of hitting the ball out of the park? The pros will say healthcare stocks.
Dewey Steadman of research firm Canaccord is chiming in today on shares of KemPharm Inc (NASDAQ:KMPH) from a confident perspective. The analyst assumed …
KemPharm Inc (NASDAQ:KMPH) investors should be smiling from ear to ear today following the news that the company’s Investigational New Drug (IND) application for …
KemPharm Inc KemPharm Inc (NASDAQ:KMPH) shares are falling over 25% after the FDA issued a complete response letter (CRL) to the company for Apadaz, an …
